Citadel Advisors’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-16,900
Closed -$30K 8563
2017
Q1
$30K Sell
16,900
-15,300
-48% -$85.9K ﹤0.01% 7173
2016
Q4
$246K Buy
32,200
+12,900
+67% +$237K ﹤0.01% 5970
2016
Q3
$831K Buy
19,300
+4,200
+28% +$190K ﹤0.01% 4073
2016
Q2
$780K Buy
15,100
+9,000
+148% +$539K ﹤0.01% 3887
2016
Q1
$339K Sell
6,100
-7,300
-54% -$378K ﹤0.01% 4933
2015
Q4
$731K Buy
13,400
+6,100
+84% +$389K ﹤0.01% 3981
2015
Q3
$590K Buy
+7,300
New +$753K ﹤0.01% 4565

Other funds holding ADPT

Citadel Advisors's ADPT Position: Q2 2017 in Review

Citadel Advisors sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 69,607 shares — an estimated $125K sold.

Citadel Advisors first reported a position in ADPT in Q4 2014 and held it in 10 quarters. The position peaked at $25.5M in Q3 2015. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Citadel Advisors reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 69,607 Adeptus Health Inc shares in Q2 2017, an estimated $125K.
  • Citadel Advisors first reported a position in Adeptus Health Inc in Q4 2014 and held it in 10 quarters.
  • Citadel Advisors's Adeptus Health Inc position peaked at $25.5M in Q3 2015.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.